• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 9
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue9

A Study to Evaluate Pattern of Rifampicin Resistance in Seropositive HIV Patients in Tertiary Care Center in Western Uttar Pradesh

    Dr. Devinder Kumar Vohra Dr. Santosh Mittal Dr. Deepa Yudik Taba

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 9, Pages 59-67

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

INTRODUCTION: Tuberculosis in the PLHIV population is a major cause of morbidity and mortality and presents a substantial hazard of nosocomial disease transmission to other patients and health care workers. These risks are heightened when patients have multidrug-resistant TB. To address these challenges, there is a critical need in such a setting for rapid, ef ective screening for TB and the detection of drug resistance and early initiation of treatment. Delayed treatment is associated with higher morbidity and mortality. METHOD: This was a cross-sectional survey among HIV infected adult patients attending A.R.T Nodal centers, Medicine Opd and ward and chest, and T.B OPD and wards. All the patients with presumptive pulmonary TB were assessed for sputum for microscopy AFB and underwent Drug susceptibility test (CBAAT) for Rifampicin resistance. The primary aim of the Study is “TO EVALUATE PATTERN OF RIFAMPICIN RESISTANCE IN SEROPOSITIVE HIV PATIENTS IN TERTIARY CARE CENTER IN WESTERN UTTAR PRADESH” RESULT: The present study concluded that the prevalence of sputum positive pulmonary tuberculosis is very high of 39% among presumptive pulmonary tuberculosis patients. BY using CBNAAT we found that 27% of rifampicin resistance was prevalent among 78 patients. In the study population maximum sputum, positive pulmonary tuberculosis was in-between age group 31 to 50 years. Majority 81% of the patients were male. CONCLUSION: Sputum microscopy has very low sensitivity (35.9%) in our study for diagnosing tuberculosis in PLHIV. whereas CBNAAT has a sensitivity of 95 %,it detected double numbers of patients than AFB microscopy
Keywords:
    MDR TUBERCULOSIS/RRTB RIFAMPICIN-RESISTANCE CBNAAT PLHIV
  • PDF (202 K)
  • XML
(2020). A Study to Evaluate Pattern of Rifampicin Resistance in Seropositive HIV Patients in Tertiary Care Center in Western Uttar Pradesh. European Journal of Molecular & Clinical Medicine, 7(9), 59-67.
Dr. Devinder Kumar Vohra; Dr. Santosh Mittal; Dr. Deepa Yudik Taba. "A Study to Evaluate Pattern of Rifampicin Resistance in Seropositive HIV Patients in Tertiary Care Center in Western Uttar Pradesh". European Journal of Molecular & Clinical Medicine, 7, 9, 2020, 59-67.
(2020). 'A Study to Evaluate Pattern of Rifampicin Resistance in Seropositive HIV Patients in Tertiary Care Center in Western Uttar Pradesh', European Journal of Molecular & Clinical Medicine, 7(9), pp. 59-67.
A Study to Evaluate Pattern of Rifampicin Resistance in Seropositive HIV Patients in Tertiary Care Center in Western Uttar Pradesh. European Journal of Molecular & Clinical Medicine, 2020; 7(9): 59-67.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 282
  • PDF Download: 322
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus